Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant <em>Pseudomonas aeruginosa</em> Infections
<i>Pseudomonas aeruginosa</i> is one of the most common causes of healthcare-associated diseases and is among the top three priority pathogens listed by the World Health Organization (WHO). This Gram-negative pathogen is especially difficult to eradicate because it displays high intrinsi...
Saved in:
Main Authors: | Dana Holger (Author), Razieh Kebriaei (Author), Taylor Morrisette (Author), Katherine Lev (Author), Jose Alexander (Author), Michael Rybak (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR <i>Enterococcus faecium</i>
by: Katherine Lev, et al.
Published: (2022) -
Utility of lytic bacteriophage in the treatment of multidrug-resistant <i> Pseudomonas aeruginosa</i> septicemia in mice
by: Vinodkumar C, et al.
Published: (2008) -
Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review
by: Zahra Chegini, et al.
Published: (2020) -
Bacteriophage-Antibiotic Combination Therapy against <i>Pseudomonas aeruginosa</i>
by: Guillermo Santamaría-Corral, et al.
Published: (2023) -
Pseudomonas aeruginosa multirresistente: um problema endêmico no Brasil Multidrug-resistant Pseudomonas aeruginosa: an endemic problem in Brazil
by: Patrícia R. Neves, et al.
Published: (2011)